InMed Pharmaceuticals Inc.
INM
$0.88
-$0.01-1.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.45% | 3.43% | 15.68% | 17.63% | -53.47% |
| Total Depreciation and Amortization | 0.83% | 19.53% | 1.16% | 0.39% | -10.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 346.30% | -63.76% | -10.24% | 77.54% | 9.36% |
| Change in Net Operating Assets | -921.02% | 67.39% | -168.16% | 383.85% | 71.51% |
| Cash from Operations | -47.81% | 9.61% | -7.17% | 33.68% | -36.97% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 199.63% | 640.79% | -61.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 77.85% | -4,001.99% | 73.78% | 69.97% |
| Cash from Financing | 100.00% | -101.68% | 179.96% | 762.60% | -59.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -36.19% | -127.28% | 407.46% | 158.25% | -118.85% |